Pfizer (PFE)

R&D to Revenue

18.68%

Quarterly · Period ending:

PFE logo

PFE R&D to Revenue

Latest reported18.68%
PFE Quarterly R&D/Revenue (0.00% → 18.68%)
High-resolution chart · PNG

PFE r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer R&D to Revenue — Quarterly
Period endingR&D to Revenue
14.5199%
13.4467%
15.5811%
14.2262%
15.4239%
16.5006%
16.8627%
17.3848%
17.6502%
16.6794%
18.0548%
16.5165%
15.7996%
15.1243%
16.5046%
15.4169%
15.8256%
18.1546%
0%
19.6575%
0%
0%
0%
18.9482%
19.0975%
17.7702%
0%
20.0974%
18.5618%
17.8022%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.